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ABSTRACT 
In recent years various Microbiomes (Skin, Gut Lumen) of the human body have attracted the attention of different research groups. In the meantime 
it has been shown that the conventional therapy of different diseases by making use of antibiotics and similar antibacterial treatments may disturb 
the harmony of the Skin Microbiome, resulting in dysbiosis. There are efforts of using “live” or “tyndallized (lysed)” probiotics in order to treat 
different diseases of the skin. It is also known that amino acids are one of the important key elements of the skin. In this paper, a hypothesis for the 
utilization of yogurt as an excipient for various topical dermatological products will be proposed. Yogurt contains significant amounts of; Probiotics 
(starter cultures), Amino Acids, Vitamins, Minerals and various Fatty Acids (saturated, monounsaturated and polyunsaturated). Besides, it has been 
shown that Antimicrobial Peptides (Bacteriocins) are also present in yogurt. Yogurt could eventually be used as an excipient for the production of 
various topical dermatological products in order to deliver some of the above-mentioned constituents to the Stratum Corneum (Skin) locally.  
Hypothesis Article 
YOGURT; A NOVEL EXCIPIENT (WITH ITS LYSED BACTERIA, AMINO ACIDS, VITAMINS, 
FATTY ACIDS, AND MINERALS) FOR “TOPICAL DERMATOLOGICAL PRODUCTS” AND FOR 
“SKIN MICROBIOTA” 
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INTRODUCTION 
After exploration of the importance of Probiotic microorganisms 
like Lactobacillus species, Bifidobacterium species and their 
importance for “Human Gut Lumen Microbiota” and for “Skin 
Microbiota”, scientific work upon this field is growing in an 
exponential manner. Because of the importance of probiotics for 
gut microbiota, and the importance of gut microbiota for human 
health and the immune system, probiotics attract the attention of 
many groups [1-10]. Different articles report interesting results, 
i.e. anti-cancer properties of bioactive peptides from synbiotic 
yogurt [5], antibacterial activity of bacteriocin isolated from 
lactobacillus bulgaricus [6], one article contemplates the probiotics 
as undervalued conquerors [8], one review article reports about 
the anti-aging properties of probiotics [9], another article reports 
about the role of gut microbiota in lipid metabolism, cholesterol 
levels and the positive effect of probiotics in infants with atopic 
dermatitis [10]. Since yogurt also contains probiotics, it can 
eventually be an important candidate as an excipient for various 
topical dermatological products. As an example of utilizing yogurt 
as a major excipient for topical dermatological products, we are 
working on a topical ointment using yogurt as one of the main 
excipients, in excess of 50%. Besides yogurt, Dexpanthenol, Olive 
Oil, Almond Oil and other necessary ingredients for emulsion 
formation and antimicrobial agents are being used. The resulting 
ointment has acceptable organoleptic, microbiological, physical-
chemical properties and stability (unpublished results). It has 
been reported by different authors, that probiotic bacteria are 
lysed by heat at elevated temperatures (70–100 °C). Following the 
lysation of probiotic bacteria, favorable cell contents for the skin 
microbiome, including Antimicrobial Peptides (Bacteriocins) are 
excreted [4-6]. Recent studies report that Antimicrobial Peptides 
(Bacteriocins) are also present in yogurt, which seem to be stable 
at elevated temperatures, i.e. 80 °C [6]. It has also been shown by 
different publications and patents that the “lysates” of probiotics 
are at least as effective as their “live” forms in inhibiting various 
pathogenic bacteria, either in the gut lumen and/or skin surface 
[7, 11-14]. The conventional method of manufacturing topical 
dermatological products is performed at elevated temperatures 
(i.e. 80 °C) and under turbulent homogenization. Considering the 
fact that probiotic bacteria would be lysed at elevated 
temperatures, it is highly probable that the probiotics in yogurt, 
when yogurt is used as an excipient for topical dermatological 
products, should also be in the lysed form following the 
production of the corresponding ointment. Besides, the added 
antimicrobial agents would also be contributing to this lysation process. 
Not to be forgotten is the fact that yogurt is not only rich in probiotics. 
Besides probiotic bacteria, yogurt is rich in Amino Acids (amino acids 
make up 40% of the skin’s Natural Moisturizing Factor/NMF) [15], 
Vitamins, Fatty Acids, and Minerals [16]. It can be assumed that only 
very small fractions of Amino Acids, Vitamins, Fatty Acids and Minerals 
will reach the skin surface following systemic application of these 
ingredients in various dosage forms. In case the skin, i.e. the Stratum 
Corneum is directly targeted, yogurt could eventually be used as an 
excipient for various topical dermatological products, for supplying the 
skin with; Lysed Probiotic Bacteria, Amino Acids, Vitamins, Fatty Acids 
and Minerals, locally. It seems as if there is quite some work to be done 
upon this field. 
Hypothesis 
Yogurt 
The word “yogurt” is a Turkish word. It is believed to have come 
from the word “yoğurmak” which means to thicken, coagulate and 
curdle [17, 18]. Yogurt is a fermented milk product. Following 
fermentation, the main structure of yogurt consists of a casein gel. In 
between, there are empty spaces filled with a liquid phase known as 
whey, which is the liquid part of milk left after fermentation. Some of 
these spaces are filled with starter bacteria [1]. The main starter 
cultures/bacteria which are used for the production of yogurt are; 
“Streptococcus thermophilus” and “Lactobacillus bulgaricus”. S. 
thermophilus is an aerobic and L. bulgaricus an anaerobic bacterium 
[1, 2, 17, 18]. Both bacteria cooperate for the fermentation of milk. 
As a result, from lactose in milk, lactic acid is produced. The pH will 
be more acidic, where the growth of other bacteria is unfavored. 
During this cooperation, S. thermophilus produces pyruvic acid, 
formic acid and carbon dioxide, which in turn stimulate the growth 
of L. bulgaricus. L. bulgaricus produces peptides and amino acids 
which promote the growth of S. thermophilus [19]. According to 
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FAO/WHO, these two bacteria fulfill the definition of probiotic 
bacteria. FAO/WHO defines Probiotics as; “live microorganisms, 
which when administered in adequate amounts, confer a health 
benefit on the host” [3]. According to Guarner et al. [20], taken here 
“word by word” from the corresponding publication; “a number of 
human studies have clearly demonstrated that yoghurt containing 
viable bacteria (Streptococcus thermophilus and Lactobacillus 
delbrueckii sp. Bulgaricus) improve lactose digestion and eliminate 
symptoms of lactose intolerance. Thus, these cultured bacteria 
clearly fulfill the current concept of probiotics”.  
Nutrient composition of yogurt  
USDA National Nutrient Database for Standard Reference [16], has 
reported the nutrient composition of “Plain Yogurt/Whole Milk” in 
its “4/1/2019 Release”. The relevant nutrients, excluding the ones 
under the title “Others”, are presented in table 1. Besides 
nutrients, yogurt contains probiotics like “S. thermophilus” and “L. 
bulgaricus”. Antimicrobial Peptides (Bacteriocins) are also 
identified in yogurt, which seems to be stable at elevated 
temperatures, i.e. 80 °C [4-6]. 
  
Table 1: Nutritional value of plain, whole milk yogurt. From USDA. Composition of Yogurt/nutrients in 100g 
Proximates 100g Amino acids  100g Reference 
Water  87,90g Tryptophan 0,020g [16] 
Protein  3,47g Threonine 0,142g 
Total Lipid (Fat) 3,25g Isoleucine 0,189g 
Carbohydrate 4,66g Leucine 0,350g 
Sugars 4,66g Lysine 0,311g 
  Methionine 0,102g 
 Minerals 100g  Cystine 0,032g 
Calcium, Ca 121 mg Phenylalanine 0,189g 
Iron, Fe 0,05 mg Tyrosine 0,175g 
Magnesium, Mg 12 mg Valine 0,287g 
Phosphorus, P 95 mg Arginine 0,104g 
Potassium, K 155 mg Histidine 0,086g 
Sodium, Na 46 mg Alanine 0,148g 
Zinc, Zn 0,59 mg Aspartic acid 0,275g 
Copper, Cu 0,009 mg Glutamic acid 0,679g 
Manganese, Mn 0,004 mg Glycine 0,084g 
Selenium, Se 2,2µg Proline 0,411g 
Fluroride, F 12µg Serine 0,215g 
    
Vitamins 100g Lipids 100g 
Vit C (total Ascorbic acid)  0,5 mg Fatty acids, total saturated 2,096g 
Thiamin, Vit B1 0,029 mg 4:0 0,096g 
Riboflavin 0,142 mg 6:0 0,066g 
Niacin 0,075 mg 8:0 0,042g 
Panthotenic acid 0,389 mg 10:0 0,093g 
Vit B6 0,032 mg 12:0 0,111g 
Folate Total 7µg 14:0 0,343g 
Carotene, beta 5µg 16:0 0,886g 
Choline Total 15,2 mg 18:0 0,317g 
Vit B12 0,37µg Fatty acids, total monounsaturated 0,893g 
Retinol 27µg 16:1  0,071g 
Vit A, RAE 27µg 18:1  0,743g 
Vit E, (alpha-tocopherol) 0,06 mg 20:1  0 
Vit D (D2+D3) 0,1µg 22:1  0 
Vit D3 (cholecalciferol) 0,1µg   
Vit D 2 IU Fatty acids, total polyunsaturated 0,092g 
Vit K (phylloquinone) 0,2µg 18:2  0,065g 
  18:3  0,027g 
  18:4 0 
  20:4  0 
  20:5 n-3 (EPA) 0 
  22:5 n-3 (DPA) 0 
  22:6 n-3 (DHA) 0 
  Cholesterol 13 mg 
 
Considering yogurt as an excipient for various topical 
dermatological products from the aspect of amino acids, 
vitamins, and minerals 
As an example of utilizing yogurt as an excipient for topical 
dermatological products, we are working on a topical ointment 
using yogurt as the main excipient, in excess of 50%. Besides Yogurt, 
Dexpanthenol, Olive Oil, Almond Oil, and Antimicrobial Agents, other 
necessary ingredients for emulsion formation are being used. The 
resulting ointment has acceptable organoleptic, physical-chemical, 
microbiological properties and stability (unpublished results). For 
the sake of simplicity, let us consider that we use, besides other 
necessary ingredients for emulsion formation and antimicrobials, 
50%/50g yogurt in a 100g ointment. We can then, depending on 
table 1, calculate the amount of amino acids, vitamins, minerals and 
lipids which would be present in such a formulation (excluding the 
lipids coming from the other ingredients). In table 2, the amount of 
nutrients in 50g yogurt are also calculated depending on the data of 
USDA [16]. Since we aim at using 50%/50g yogurt in our 
hypothetical formulation, the nutrients which are present in 50g 
yogurt should be present in our 100g hypothetical formulation. In 
our preliminary studies, we were able to reassess the amount of 
amino acids in our finished topical formulation, which was 
proportional to the amounts of amino acids in the yogurt sample 
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used (unpublished results). We have “not” done similar studies for 
the vitamins, minerals and lipids. In the corresponding columns 
of table 2, depending on the data of USDA [16], the amount of 
amino acids, minerals, vitamins, and lipids which would be 
present in 1g of the above mentioned hypothetical 100g 
ointment are calculated. 1g ointment also corresponds to 2 
Finger Tip Units (FTU). The details for FTU for an adult male 
fingertip is given below [21]: 
  
Table 2: Amount of nutrients in 50g yogurt and in 1g (2 FTU) of a hypothetical ointment containing 50%/50g yogurt. The amounts are 
calculated depending on the yogurt data of USDA, from table 1 
Minerals 50g  1g Ointment (2FTU) Amino acids 50g 1g Ointment (2 FTU) Reference 
Calcium, Ca 60,5 mg 605µg Tryptophan 0,010g 100µg [16] 
Iron, Fe 0,025 mg 0.25µg Threonine 0,71g 7100µg 
Magnesium, Mg 6 mg 60µg Isoleucine 0,0945g 945µg 
Phosphorus, P 47,5 mg 475µg Leucine 0,175 1750µg 
Potassium, K 77,5 mg 775µg Lysine 0,1555g 1555µg 
Sodium, Na 23 mg 230µg Methionine 0,051g 510µg 
Zinc, Zn 0,295 mg 2.95µg Cystine 0,016g 160µg 
Copper, Cu 0,0045 mg 0.045µg Phenylalanine 0,0945g 945µg 
Manganese, Mn 0,002 mg 0.02µg Tyrosine 0,0875g 875µg 
Selenium, Se 1,1µg 0.011µg Valine 0,1435g 1435µg 
Fluroride, F 6µg 0.06µg Arginine 0,052g 520µg 
Vitamins 50g 1g Ointment (2 FTU) Histidine 0,043g 430µg 
Vit C (total Ascorbic acid) 0,25 mg 2.5µg Alanine 0,074g 740µg 
Thiamin, Vit B1 0,0145 mg 0,145µg Aspartic acid 0,1375g 1375µg 
Riboflavin 0,071 mg 0.71µg Glutamic acid 0,3395g 3395µg 
Niacin 0,0375 mg 0,375µg Glycine 0,042g 420µg 
Panthotenic acid 0,1945 mg 1.945µg Proline 0,2055g 2055µg 
Vit B6 0,016 mg 0,16µg Serine 0,1075g 1075µg 
Folate Total 3,5µg 0,035µg Lipids 50g 1g Ointment (2 FTU) 
Folic acid 0 0 Fatty acids, total 
saturated 
1,048g 10480µg 
Choline 7,6 mg 76µg 4:0 0,048g 480µg 
Vit B12 0,185µg 0,00185µg 6:0 0,033g 330µg 
Retinol 13,5µg 0,135µg 8:0 0,021g 210µg 
Vit A, IU 49,5 IU 0,495 IU 10:0 0,0465g 465µg 
Vit E, (alpha-tocopherol) 0,03 mg 0,3µg 12:0 0,0555g 555µg 
Vit D (D2+D3) 0,05µg 0,0005µg 14:0 0,1715g 1715µg 
Vit D3 (cholecalciferol) 0,05µg 0,0005µg 16:0 0,443g 4430µg 
Vit D 1 IU 0,01 IU 18:0 0,1585g 1585µg 
Vit K (phylloquinone) 0,1µg 0,001µg Fatty acids, total 
monounsaturated 
0,4465g 4465µg 
   16:1 
undifferentiated 
0,0355g 355µg 
   18:1 
undifferentiated 
0,3715g 3715µg 
   20:1  0 0 
   22:1 
undifferentiated 
0 0 
   Fatty acids, total 
polyunsaturated 
0,046g 460µg 
   18:2 
undifferentiated 
0,0325g 325µg 
   18:3 
undifferentiated 
0,0135g 135µg 
   18:4 0 0 
   20:4 
undifferentiated 
0 0 
   20:5 n-3 (EPA) 0 0 
   22:5 n-3 (DPA) 0 0 
   22:6 n-3 (DHA) 0 0 
   Cholesterol 6,5 mg 65µg 
 
The quantity of cream in a Finger Tip Unit (FTU) varies with age [21]: 
- Adult male: 1 finger-tip unit provides 0.5g 
The necessary FTU for different body areas are given below [21]: 
- One hand 1 FTU 
- One arm 3 FTU 
- One foot 2 FTU 
- One leg 6 FTU 
- Face and neck 2,5 FTU 
- Trunk, front and back 14 FTU 
- Entire body about 40 FTU 
Supposing that we would like to use the hypothetical ointment for 
the treatment of “One Adult Foot”.  
We would then need 2 FTU=1g ointment, as expressed above. The 
corresponding amount of nutrients that would be delivered by the 
hypothetical 1g ointment are shown in table 2.  
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Questions about the fraction of an amino acid dose reaching the 
stratum corneum following systemic application 
Amino acids are, among others, breakdown products of filaggrin 
which is important for proper epidermal differentiation and skin 
barrier function.  
The amino acids and the other byproducts of filaggrin contribute to 
the formation of  the Natural Moisturizing Factor (NMF) [22] as 
shown in table 3 [15]. The Confocal Raman Spectroscopy depth 
measurements indicate that the NMF concentration is higher in the 
whole Stratum Corneum of the human skin [23]. 
  
Table 3: Chemical composition of the Natural Moisturizing Factor/NMF 
Free Amino Acids 40% Reference [15] 
Pyrrollidone carboxylic acid 12% 
Lactate  12% 









Citrate, formate 0,5% 
 
As far as our surveys about the data in the scientific literature are 
concerned, we do not know what fraction of a systemically applied 
amino acid dose would reach the Skin/Stratum Corneum. For many 
drugs, the term Volume of Distribution (pharmacokinetics) is used 
as a calculation factor to approximately calculate the amount of drug 
in the body at any time, by making use of i.e. plasma concentrations. 
As an example, let us take the Volume of Distribution of the amino 
acid Arginine, which is given to be around 24 liters, assessed in 
humans. The authors [24] have infused 3g of L-Arginine to humans 
and have measured “peak plasma concentrations” of approximately 
400 µmoles/liter, which corresponds to approximately 70µg/ml for 
L-Arginine.  
The U. S. Food and Nutrition Board has published the Recommended 
Dietary Allowances for various amino acids for adults. Depending on 
the type of amino acid, the amounts vary between 8–14 mg per kg of 
body weight [25]. If we consider an average value of 10 mg/kg 
allowance for a certain amino acid, for an average person of 75 kg 
body weight, the total dietary allowance would be around 0,75g. As 
cited above, after an infusion of 3g L-Arginine, the peak plasma 
concentrations are measured to be approximately 70µg/ml [24]. After 
systemic application of 0,75g amino acid, the plasma concentrations 
should be considerably lower (assuming 100% bioavailability and no 
“first-pass-effect” following peroral application). It can be assumed that 
only very small fractions of the amount present in the plasma would 
reach the Skin Surface/Stratum Corneum.  
Looking at table 2, it can be seen that relative significant amounts of 
amino acids can be delivered locally to the stratum corneum by 
utilization of yogurt as an-excipient in a topical dermatological 
product.  
Amino acids make up 40% of the skin’s Natural Moisturizing 
Factor/NMF. The other constituents of the NMF besides amino acids 
are given in table 3 [15]. One could eventually achieve significant 
moisturization of the skin by delivering amino acids, minerals, and 
the humectant lactic acid (which is one of the major constituents of 
yogurt) by means of a topical yogurt containing ointment locally.  
As shown in table 1, besides amino acids, yogurt also contains 
significant amounts of vitamins, minerals, and lipids. We have not 
studied the fate and proportional transfer of vitamins, minerals, and 
lipids from the yogurt samples used. They may or may not have been 
degraded during the manufacturing process. There seems to be 
quite some work to be done upon this field. 
Considering yogurt as an excipient for topical dermatological 
products from the aspect of lysed probiotics  
The skin Microbiome 
Since the Skin Microbiome is the main scope of this paper, various 
other Microbiomes of the human body will not be discussed. 
In their very interesting paper, Grice and Segre [26], have presented 
the schematic of the skin histology in a cross-sectional form. 
Microorganisms, like viruses, bacteria, and fungi are schematized on 
the surface of the skin, which also reside in sweat glands, sebaceous 
glands, hair and hair shaft. Rod-shaped and round bacteria, like 
Proteobacteria and Staphylococcus spp., commensal fungi like 
Malassezia spp. and skin mites (i.e. Demodex folliculorum, Demodex 
brevis) are also schematized for the reader in a brilliant and very 
understandable scheme. All these microorganisms live in 
communities and in close association with each other. Major 
examples of the 19 phyla which are known to be part of the skin 
microbiome are; Actinobacteria (51, 8%), Firmicutes (24, 4%), 
Proteobacteria (16,5%) and Bacteriodetes. The major genera are 
Corynebacterium, Propionibacterium, and Staphylococcus [27]. The 
skin is an ecosystem of, microorganisms and host, existing in balance 
and harmony. The disturbance of this homeostasis may lead to 
different diseases [26, 27]. On the other hand, this homeostasis may 
also be misbalanced by exogenous agents, used for the treatment of 
various dermatological disorders. This should perhaps lead us to re-
evaluate our understanding of treating various diseases, i.e. the 
unnecessary use of antibiotics, which may disturb the microbiome 
balance and harmony, resulting in dysbiosis. In such cases, it may 
take long periods for the microbiome to recover [27, 28]. 
Use of lysed probiotics and their effect on the skin 
It has been shown by different publications and patents that the 
“lysates” of probiotics are at least as effective as their “live” forms in 
inhibiting various pathogenic bacteria, either in the Gut Lumen 
and/or Skin Surface [7, 11-14, 29, 30]. 
Since it is not the scope of this paper to discuss the effects of “live 
probiotics” on the skin microbiome, solely the effect of “lysed 
probiotics” will be discussed. As already implemented above, 
FAO/WHO defines Probiotics as; “live microorganisms, which when 
administered in adequate amounts, confer a health benefit on the 
host” [3]. According to Guarner et al. [20], taken here from the 
corresponding publication “word by word”; “a number of human 
studies have clearly demonstrated that yoghurt, containing viable 
bacteria (Streptococcus thermophilus and Lactobacillus delbrueckii 
sp. Bulgaricus), improve lactose digestion and eliminate symptoms 
of lactose intolerance. Thus, these cultured bacteria clearly fulfill the 
current concept of probiotics”. 
Pique et al. mention different methods for the inactivation/lysation 
of probiotic bacteria. The mentioned methods are; heat (70–100 °C), 
chemicals like formalin, gamma or ultraviolet rays and sonication. 
The preferred method being heat inactivation. Inactivation ruptures 
the cell walls of the probiotic bacteria, thereby releasing the 
cytoplasmic contents, i.e.; DNA and cell wall components like 
Peptidoglycans, Lipoteichoic acids or heat-labile Pilli. They cite that 
the excreted components play key immunomodulating roles, i.e. 
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production of IgA by “S. thermophilus lysates” and anti-inflammatory 
responses mediated by metabolites and cell surfaces of “L. 
delbrueckii”. The authors cite that the lysate components of heat-killed 
probiotics would inhibit pathogens and also release Antimicrobial 
Peptides (Bacteriocins) which are effective against Gram-positive and 
Gram-negative bacteria [11]. Lew and Liong cite that the cell wall 
fragments of probiotic bacterial extracts, their metabolites and the 
dead probiotic bacteria as such, can improve skin barrier functions and 
regulate immune responses. One of the components of lysed S. 
thermophilus, the Sphingomyelinase enzyme, when applied in cream 
was able to increase the ceramide levels on the volar forearm of 
healthy human volunteers significantly (p<0.05) within a week. Other 
cell components, like Lipoteichoic acid, increases dermal cellular 
defense against bacterial infection and Peptidoglycan plays an 
important role in defending the skin against pathogens [12].  
Shigwedha et al. name the “probiotical cell fragments (PCFs)” of 
probiotics as “parabiotics” since they do not represent intact 
bacteria. They also cite that the cell components of such bacteria, i.e. 
Peptidoglycan, Lipoteichoic acid, cell wall-associated Polysaccharides, 
Muramyl peptide, Muramyl dipeptide, when applied intestinally 
would exert beneficial effects. They mention that these cell 
fragments inhibit the adhesion of C. perfringens, E. coli, S. 
thyphimurium, C. difficile, Shigella sp. and Salmonella sp. to mucus 
and/or intestinal epithelial cells in a competitive way [7]. 
Di Marzio et al. have shown that sonicated (lysed) S. thermophilus 
strains, “which is one of the starter bacteria for yogurt”, when 
applied topically to patients suffering from atopic dermatitis, 
increased the level of ceramides in the stratum corneum thereby 
improving barrier function [29]. 
In one patent application [30], the inventors describe the use of lysed 
probiotic bacteria against skin infections. Lysates of Lactobacillus 
rhamnosus GG, was shown to inhibit Staphylococcus aureus infection 
by preventing the adhesion of St. aureus to cells. They also cite that 
these lysates can be administered in different dosage forms, including 
liposomes and other microparticulate dosage forms. 
In a thesis submitted to the University of Manchester Medical Faculty, it 
is cited that lysates of Lactobacillus rhamnosus GG was effective against 
the adhesion of St. aureus to keratinocytes thereby counteracting 
infections. It has also been shown that L. rhamnosus GG lysates also 
enhance the re-epithelization of wounds, favoring keratinocyte terminal 
differentiation. The study cites that L. rhamnosus GG lysates can be used 
as a therapeutic agent to enhance wound healing [13].  
Gueniche et al., cite that lysates of Bifidobacterium longum spp. 
would improve sensitive skin. Skin sensitivity was assessed by the 
stinging test. Following barrier disruption, skin recovery was 
evaluated by measuring the Trans-Epidermal Water Loss (TEWL), in 
a double-blind, randomized, placebo-controlled trial, where a 10% 
cream of B. longum spp. lysate was applied. The results show that the 
volunteers who used the extract in a cream form had a significant 
drop in skin sensitivity and a significant decrease in skin dryness at 
the end of the treatment [14].  
Tufail et al., isolated Bacteriocins (Antimicrobial Peptides) from 
Lactobacillus bulgaricus (which is one of the starter cultures of 
yogurt) and tested the inhibitory activity against B. subtilis, E. coli, S. 
typhi, St. aureus, V. cholerae by use of the agar diffusion method. 
They cite that the isolates have antibacterial potential against the 
mentioned pathogens [6]. 
To give the reader a picture about the amount of “L. bulgaricus and S. 
thermophilus” in yogurt, which are the main probiotics (starter 
bacteria) for yogurt production, the viable bacterial counts in yogurt 
are given below in table 4. 
 
Table 4: The viable bacterial counts in Yogurt [2, 31] 
Yilmaz-Ersan L, Kurdal E.  Reference [2] 
S. thermophilus 9,01 (log cfu/ml) 
L. bulgaricus 8,42 (log cfu/ml) 
Sarvari F, Mortazavian AM, Fazeli MR  Reference [31] 
S. thermophilus 8,72 (log cfu/ml) 
L. bulgaricus 8,48 (log cfu/ml) 
 
CONCLUSION 
The utilization of yogurt as an excipient for various topical 
dermatological products is discussed. If such an ointment, where 
yogurt is used as an excipient, is manufactured by conventional 
methods (elevated temperatures and turbulent homogenization), 
under such conditions the major probiotic bacteria used for 
yogurt production (in this case S. thermophilus and L. bulgaricus) 
should be in the lysed state following the production of the 
ointment. In addition to heat and turbulent homogenization, the 
added antimicrobial agent(s) would also support this lysation 
process. 
Many groups have shown that “lysed probiotics” exert favorable 
effects on the skin. These effects were shown to be at least as 
favorable as the “live forms” of the corresponding probiotics. Apart 
from using S. thermophilus and L. bulgaricus as starter cultures for 
yogurt production, different probiotics (starter cultures) may also be 
used. The corresponding yogurt samples (with different starter 
cultures) could perhaps be used in ointments, depending on the 
targeted effect to be achieved. Using yogurt as an excipient for a 
certain topical dermatological product could be promising for the 
future, since such a formulation may deliver significant amounts of; 
“Lysed Probiotics”, “Amino Acids (amino acids make up 40% of the 
skin’s Natural Moisturizing Factor/NMF)”, “Vitamins and fatty acids 
(it needs to be assessed whether the vitamins and the fatty acids are 
transferred from yogurt to the final formulation without 
degradation)” and “Minerals” to the Stratum Corneum, locally.  
OVERVIEW 
The utilization of yogurt as an excipient for various topical 
dermatological products is discussed. Yogurt contains live probiotics 
as such, which are shown to be exerting favorable effects in the 
human body. On the other hand, as cited in the above text, many 
groups have also shown that “lysed probiotics” also exert favorable 
effects in the human body and the skin locally. Using yogurt as an 
excipient for a certain topical dermatological product could be 
promising, since such a formulation may also deliver significant 
amounts of; Lysed Probiotics, Amino Acids (amino acids make up 
40% of skin’s Natural Moisturizing Factor/NMF), Fatty Acids, 
Minerals and Vitamins to the stratum corneum locally. We were able 
to reassess the proportional corresponding amounts of amino acids 
in the final topical formulation that were present in the yogurt 
samples used (unpublished results). But no further studies were 
done in order to determine if all the Vitamins and Fatty Acids in the 
yogurt sample are transferred to the ointment intact, without 
degradation. Further studies are needed in order to investigate the 
utilization of yogurt as an excipient in topical dermatological 
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